GSK chief calls on European governments to work with industry on defining value
This article was originally published in SRA
Executive Summary
Andrew Witty, chief executive of GlaxoSmithKline and president of the European Federation of Pharmaceutical Industries and Associations, has called on European policy makers and pharmaceutical companies to work together to provide European citizens equal access to the right medicines and vaccines1. Speaking in Brussels at the "21st Century Healthcare for Europe" conference, Mr Witty acknowledged the need to restore the covenant between industry and governments.